Concepedia
Statistics
Publications
8
Citations
204
H-Index
Active since
1987
Affiliations
Boehringer Ingelheim (Germany)(Current)
Boehringer Ingelheim (Canada)
W.S. Adamus is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacology, and pharmacodynamics.
Publications per year
1987–1995
Inhibitory effects of the new PAF acether antagonist WEB-2086 on pharmacologic changes induced by PAF inhalation in human beings
W.S. Adamus, H. Heuer, Christopher J. Meade et al. · Clinical Pharmacology & Therapeutics · 1990 · 58 citations
Medicine, Pharmacology, Pharmacotherapy +12
Neuroendocrine and side effect profile of pramipexole, a new dopamine receptor agonist, in humans
Julian Schilling, W.S. Adamus, Rainer Palluk · Clinical Pharmacology & Therapeutics · 1992 · 41 citations
Medicine, Endocrinology, Pharmacology +16
Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's disease
W.S. Adamus, Joachim Leonard, Wolfgang Tröger · Life Sciences · 1995 · 27 citations
Medicine, Neuroscience, Pharmacology +16
Safety, tolerability., and pharmacologic activity of multiple doses of the new platelet activating factor antagonist WEB 2086 in human subjects
W.S. Adamus, H. Heuer, Christopher J. Meade et al. · Clinical Pharmacology & Therapeutics · 1989 · 26 citations
Medicine, Pharmacology, Pharmacotherapy +13
Pharmacodynamics, pharmacokinetics and safety profile of the new platelet-activating factor antagonist apafant in man.
H. M. Brecht, W.S. Adamus, H. Heuer et al. · PubMed · 1991 · 16 citations
Medicine, Pharmacokinetics, Pharmacology +12
1–5 of 8